Founded in Maryland in 1991 by pharmacist and biopharmaceutics researcher Edward D. Purich, family-run ChiRhoClin develops peptide- and protein-based medicines for pancreatic and gastrointestinal disease. The company’s FDA-approved ChiRhoStim® synthetic human secretin supports pancreatic-function testing, gastrinoma diagnosis, and pancreatic imaging, while its research partnerships and grant program keep the focus on advancing pancreas science. ChiRhoClin also operates CRC Labs, an FDA-inspected cGMP laboratory with more than 50 years of combined pharmaceutical experience among its staff.
cGMP
compliance_program
FDA Inspected Laboratory
compliance_program